tiprankstipranks
Advertisement
Advertisement

CRDF Stock Latest News

CRDF Upcoming Earnings Report: What to Expect?
Pre-EarningsCRDF Upcoming Earnings Report: What to Expect?
7d ago
CRDF
Cardiff Oncology to present preclinical data on onvansertib
PremiumThe Fly
Cardiff Oncology to present preclinical data on onvansertib
18d ago
CRDF
Cardiff Oncology appoints new CEO, CFO and COO
PremiumCompany Announcements
Cardiff Oncology appoints new CEO, CFO and COO
26d ago
8K
CRDF
Cardiff Oncology appoints Mani Mohindru CEO, Josh Muntner CFO
PremiumThe Fly
Cardiff Oncology appoints Mani Mohindru CEO, Josh Muntner CFO
26d ago
ACRS
CRDF
Cardiff Oncology Formalizes Executive Departures Amid Strategic Review
PremiumCompany Announcements
Cardiff Oncology Formalizes Executive Departures Amid Strategic Review
1M ago
8K
CRDF
Cardiff Oncology advances onvansertib program in colorectal cancer
PremiumCompany AnnouncementsCardiff Oncology advances onvansertib program in colorectal cancer
2M ago
8K
CRDF
Cardiff Oncology price target lowered to $6 from $10 at Piper Sandler
Premium
The Fly
Cardiff Oncology price target lowered to $6 from $10 at Piper Sandler
2M ago
CRDF
Cardiff Oncology: Promising Onvansertib Data and Solid Cash Runway Support Buy Rating and $10 Price Target
Premium
Ratings
Cardiff Oncology: Promising Onvansertib Data and Solid Cash Runway Support Buy Rating and $10 Price Target
2M ago
CRDF
CRDF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CRDF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CRDF
Cardiff Oncology selloff brings attractive entry point, says H.C. Wainwright
PremiumThe Fly
Cardiff Oncology selloff brings attractive entry point, says H.C. Wainwright
3M ago
CRDF
Cardiff Oncology Overhauls Leadership to Advance Onvansertib
PremiumCompany Announcements
Cardiff Oncology Overhauls Leadership to Advance Onvansertib
3M ago
8K
CRDF
Balancing Leadership Turmoil and Focused Clinical Strategy: Maintaining a Buy on Cardiff Oncology’s Onvansertib Amid Catalyst-Rich Outlook
PremiumRatings
Balancing Leadership Turmoil and Focused Clinical Strategy: Maintaining a Buy on Cardiff Oncology’s Onvansertib Amid Catalyst-Rich Outlook
3M ago
CRDF
Cardiff Oncology announces CEO Erlander, CFO Levine have stepped down
PremiumThe FlyCardiff Oncology announces CEO Erlander, CFO Levine have stepped down
3M ago
CRDF
Cardiff Oncology announces update from CRDF-004, Phase 2 trial of onvansertib
Premium
The Fly
Cardiff Oncology announces update from CRDF-004, Phase 2 trial of onvansertib
3M ago
CRDF
Cardiff Oncology initiated with an Outperform at Noble Capital
Premium
The Fly
Cardiff Oncology initiated with an Outperform at Noble Capital
4M ago
CRDF
Cardiff Oncology: Promising Clinical Results and Strong Financial Position Justify Buy Rating
PremiumRatings
Cardiff Oncology: Promising Clinical Results and Strong Financial Position Justify Buy Rating
6M ago
CRDF
Cardiff Oncology Reports Increased Losses Amid Ongoing Trials
PremiumCompany Announcements
Cardiff Oncology Reports Increased Losses Amid Ongoing Trials
6M ago
CRDF
Cardiff Oncology’s Promising Future: Buy Rating Backed by Strong Financials and Onvansertib’s Clinical Success
PremiumRatings
Cardiff Oncology’s Promising Future: Buy Rating Backed by Strong Financials and Onvansertib’s Clinical Success
6M ago
CRDF
Cardiff Oncology raises FY25 revenue view to $76M-$78M from $72M-$76M
PremiumThe Fly
Cardiff Oncology raises FY25 revenue view to $76M-$78M from $72M-$76M
6M ago
CRDF
Cardiff Oncology reports Q3 EPS (17c), consensus (21c)
PremiumThe FlyCardiff Oncology reports Q3 EPS (17c), consensus (21c)
6M ago
CRDF
CRDF Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CRDF Earnings this Week: How Will it Perform?
6M ago
CRDF
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
8M ago
ACB
BHP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >